Skip to main content

CITADEL ADVISORS LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL

Position in INO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$498,252
+$498,252 QoQ
Shares Held
286,352
Ownership
0.348%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Mar 31, 2026
CallValue
$128,064
CallShares
73,600
PutValue
$107,706
PutShares
61,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,783,571,443 across 373 Biotechnology names. INO ranks #258 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $128,064 73,600
2026-03-31 $498,252 286,352
2026-03-31 $107,706 61,900
2025-12-31 $78,126 44,900
2025-12-31 $668,508 384,200
2025-09-30 $25,974 11,100
2025-09-30 $281,970 120,500
2025-09-30 $29,020 12,402
2025-06-30 $133,416 65,400
2025-06-30 $49,164 24,100
2025-06-30 $344,669 168,956
2025-03-31 $34,882 21,400
2025-03-31 $12,551 7,700
2024-12-31 $39,762 21,728
2024-12-31 $49,702 27,160
2024-12-31 $41,797 22,840
2024-09-30 $81,382 14,080
2024-09-30 $246,621 42,668
2024-06-30 $308,235 38,148
2024-06-30 $126,371 15,640
2024-03-31 $264,053 19,024
2024-03-31 $795,601 57,320